AIMS and SCOPES:

“Innovations in Cancer Science & Clinical Therapeutics” is an international, peer-reviewed, open-access journal dedicated to publishing high-quality research and innovative developments in the field of cancer science and clinical therapeutics. The aim of the journal is to provide a platform for researchers, clinicians, and other healthcare professionals to share their knowledge, ideas, and experiences to improve cancer diagnosis, treatment, and care.

The journal accepts original research articles, review articles, case reports, and other types of articles related to the latest advances in cancer research, diagnosis, and treatment. The topics covered by the journal include, but are not limited to:

1. Cancer biology
2. Cancer genetics
3. Cancer immunology
4. Cancer stem cells
5. Cancer diagnosis and screening
6. Biomarkers in cancer diagnosis and treatment
7. Precision medicine in cancer treatment
8. Cancer drug discovery and development
9. Chemotherapy and other systemic treatments
10. Radiotherapy and other local treatments
11. Immunotherapy and other targeted treatments
12. Surgery and other local treatments
13. Palliative care and symptom management
14. Cancer survivorship and quality of life
15. Cancer epidemiology and prevention
16. Cancer disparities and health equity
17. Clinical trials in cancer research
18. Translational research in cancer science
19. Big data and artificial intelligence in cancer research
20. Ethics and policy in cancer research and care

The journal aims to publish articles that are scientifically rigorous, innovative, and impactful. The articles should contribute to the understanding of cancer biology, diagnosis, treatment, and care, and have the potential to improve the lives of cancer patients and their families.

The journal follows a double-blind peer-review process to ensure the quality and validity of the articles published. The journal is committed to upholding the highest ethical standards in publishing and adheres to the guidelines set by the Committee on Publication Ethics (COPE).

Keywords/Sub-topics:

1. Angiogenesis inhibitors
2. Apoptosis
3. Biomarkers
4. Biopharmaceuticals
5. Cancer biology
6. Cancer diagnosis
7. Cancer drug discovery
8. Cancer genetics
9. Cancer immunology
10. Cancer prevention
11. Cancer stem cells
12. Chemoprevention
13. Chemotherapy
14. Clinical trials
15. Companion diagnostics
16. Computational modeling
17. Epigenetics
18. Gene therapy
19. Genomics
20. Immunotherapy
21. Inflammation
22. Liquid biopsy
23. Metastasis
24. Microenvironment
25. Molecular imaging
26. Nanotechnology
27. Natural products
28. Oncogenes
29. Palliative care
30. Patient-centered care
31. Personalized medicine
32. Pharmacogenomics
33. Precision medicine
34. Radiotherapy

• Resistance mechanisms

36. Screening

• Signal transduction
• Surgery
• Survivorship

40. Targeted therapy
41. Tumor microenvironment
42. Tumor suppressor genes
43. Vaccines
44. Virotherapy
45. Xenograft models
46. 3D cell culture
47. Artificial intelligence
48. Big data
49. Bioinformatics
50. Biosensors
51. Cancer disparities
52. Cancer epidemiology

• Cancer health disparities

54. Cancer survivorship
55. Clinical decision support

• Clinical trials design

57. Community outreach
58. Computational biology
59. Immunotherapy
60. Genetic mutations
61. Tumor microenvironment
62. Cancer stem cells
63. Combinatorial therapy
64. Radiotherapy

• Chemotherapy

66. Surgery

• Palliative care
• Survivorship
• Biomarkers

70. Liquid biopsy
71. Tissue engineering
72. Nanoparticle delivery systems

• Clinical trials

74. Preclinical research
75. Personalized medicine

• Precision oncology

77. Big data analysis
78. Artificial intelligence
79. Machine learning
80. Data mining
81. Radiomics
82. Genomics

• Proteomics

84. Metabolomics
85. Transcriptomics

• Epigenetics

87. Cancer prevention
88. Tobacco cessation
89. HPV vaccination
90. Sun safety
91. Diet and nutrition
92. Physical activity

• Environmental factors

94. Occupational carcinogens
95. Radiation exposure

• Cancer disparities

97. Health equity
98. Global cancer burden
99. Cancer policy
100. Health economics
101. Clinical pathways
102. Cancer education
103. Patient advocacy
104. Cancer communication
105. Social media
106. Patient-centered care
107. Multidisciplinary care
108. Telemedicine
109. Digital health
110. Mobile health
111. Wearable devices
112. Oncology nursing
113. Medical oncology
114. Radiation oncology
115. Surgical oncology
116. Pathology
117. Radiology
118. Psycho-oncology
119. Supportive care
120. Symptom management
121. Pain management
122. Fatigue management
123. Nausea and vomiting
124. Neuropathy
125. Lymphedema
126. Cardiotoxicity
127. Cognitive impairment
128. Sexual health
129. Fertility preservation
130. Palliative sedation
131. Spiritual care
132. Bereavement support
133. Survivorship care plans
134. Cancer survivorship research
135. Health-related quality of life
136. Patient-reported outcomes
137. Health system strengthening
138. Cancer registry
139. Cancer data collection
140. Cancer surveillance
141. Cancer statistics
142. Targeted therapies
143. Immunotherapy
144. Precision medicine
145. Genomic testing
146. Biomarker discovery
147. Cancer prevention
148. Cancer screening
149. Cancer epidemiology
150. Oncology nursing
151. Palliative care
152. Survivorship
153. Cancer-related fatigue
154. Cancer-related pain management
155. Psycho-oncology
156. Supportive care
157. Complementary and alternative medicine
158. Health disparities in cancer
159. Cancer survivorship programs
160. Survivorship care plans
161. Cancer rehabilitation
162. Geriatric oncology
163. Cancer in adolescents and young adults
164. Cancer in children
165. Cancer genetics
166. Cancer and the environment
167. Cancer and lifestyle factors
168. Cancer and nutrition
169. Cancer and exercise
170. Cancer education and awareness
171. Cancer patient advocacy
172. Cancer policy
173. Cancer research funding
174. Ethics in cancer research
175. Cancer clinical trials
176. Big data in cancer research
177. Artificial intelligence in cancer research
178. Digital health in cancer care
179. Telemedicine in cancer care
180. Cancer health economics
181. Cancer drug pricing
182. Cancer diagnostics
183. Cancer imaging
184. Cancer surgery
185. Radiation oncology
186. Chemotherapy
187. Hormonal therapy
188. Stem cell transplant
189. Gene therapy
190. Nanotechnology in cancer treatment
191. Pharmacogenomics
192. Toxicity management
193. Cancer treatment-related side effects
194. Drug resistance in cancer
195. Cancer recurrence
196. Minimal residual disease
197. Liquid biopsy
198. Tumor microenvironment
199. Cancer metastasis
200. Cancer stem cells

 

These keywords/sub-topics cover a broad range of areas related to cancer research, treatment, prevention, and survivorship. They also highlight the multidisciplinary nature of the journal, which seeks to bring together researchers, clinicians, patient advocates, and policy makers from different fields to share their knowledge and experiences.

The journal "Innovations in Cancer Science & Clinical Therapeutics" aims to advance knowledge in the field of cancer research and provide a platform for sharing innovative and impactful ideas. The journal's scope encompasses a wide range of topics related to cancer science and clinical therapeutics, including but not limited to cancer genetics, molecular biology, immunotherapy, clinical trials, and supportive care. It aims to encourage collaboration between researchers and clinicians from different disciplines, facilitate the translation of research findings into clinical practice, and ultimately improve patient outcomes. The journal is committed to maintaining high standards of rigor and scientific integrity, and to ensuring that all published research is accessible to a global audience through its open access policy.